시장보고서
상품코드
2082193

신생아 황달 치료 시장 보고서(2026년)

Newborn Jaundice Treatment Global Market Report 2026

발행일: | 리서치사: 구분자 The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 4,490 금액 안내 화살표 ₩ 6,745,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 금액 안내 화살표 ₩ 9,750,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 금액 안내 화살표 ₩ 12,755,000
※ 부가세 별도
한글목차
영문목차

신생아 황달 치료 시장 규모는 최근 강력하게 확대되고 있습니다. 2025년 27억 1,000만 달러로 평가되었고, 2026년에는 28억 4,000만 달러로 추정되며, CAGR 5.0%로 성장할 전망입니다. 지난 몇 년간의 성장 요인으로는 전 세계적으로 신생아 황달 사례 수가 많다는 점, 자원이 제한된 지역에서 첨단 광선 요법 장비를 구하기 어렵다는 점, 기존 형광등을 이용한 치료 시스템에 대한 의존, 신생아 고빌리루빈혈증의 진단 지연, 그리고 표준화된 신생아 선별 검사 프로토콜의 부재 등을 들 수 있습니다.

신생아 황달 치료 시장 규모는 향후 몇 년간 강력한 성장이 전망되고 있습니다. 2030년까지 34억 9,000만 달러에 이를 것으로 예측되며, CAGR은 5.3%를 나타낼 전망입니다. 예측 기간 동안의 이러한 성장은 LED 기반 광선 요법 시스템의 도입 확대, 신생아 조기 선별 검사 프로그램에 대한 관심 증가, 재택 신생아 돌봄 솔루션에 대한 수요 증가, 비침습적 빌리루빈 모니터링 기술의 발전, 그리고 전 세계 신생아 중환자 치료 인프라 확충에 기인한 것으로 보입니다. 예측 기간 동안의 주요 동향으로는 신생아의 빌리루빈 수치를 신속하게 낮추는 LED 기반 집중 광선 요법 시스템, 영아의 부담을 최소화하면서 지속적인 치료를 가능하게 하는 광섬유 담요형 광선 요법, 실시간 광선 요법 조정 기능을 통합한 스마트 빌리루빈 모니터링 시스템, 조기 퇴원을 지원하는 휴대형 재택 간호용 광선 요법 장치, 신생아 집중 치료의 치료 효율을 높이는 듀얼 서피스 광선 요법 장치 등이 있습니다.

출생률 상승이 향후 몇 년간 신생아 황달 치료 시장의 성장을 견인할 것으로 예측됩니다. 출생률이란 특정 기간 동안 특정 인구 집단 내에서 태어난 신생아의 수를 말하며, 전반적인 인구 증가와 출산 양상을 반영합니다. 출생률 증가는 임산부 의료 서비스에 대한 접근성 개선, 인구 증가, 그리고 특정 지역의 정부 지원 정책에 힘입어 이루어지고 있으며, 그 결과 산후 관리가 필요한 신생아의 수가 증가하고 있습니다. 신생아 황달 치료는 광선 요법 및 관련 치료법을 통해 증가하는 신생아 인구에서 빌리루빈 수치의 조기 진단과 효과적인 관리를 지원함으로써 이러한 추세에 기여하고 있으며, 이를 통해 합병증의 위험을 줄이고 있습니다. 예를 들어, 영국 정부 기관인 국가통계청(Office for National Statistics)에 따르면, 2025년 7월 기준으로 2024년 잉글랜드 및 웨일즈의 출생 건수는 59만 4,677건으로 기록되었으며, 이는 2023년 대비 3,605건(0.6%) 증가하여 2021년 이후 처음으로 증가세를 보였습니다. 따라서 출산율 상승이 신생아 황달 치료 시장의 성장을 견인하고 있습니다.

신생아 황달 치료 시장에서 사업을 전개하는 주요 기업들은 조기 진단을 지원하고 의료 접근성을 개선하기 위해, 스마트폰을 활용한 빌리루빈 검출 기술 등 첨단 비침습적 선별 검사 솔루션에 주력하고 있습니다. 스마트폰을 활용한 빌리루빈 검출 기술은 모바일 이미지와 알고리즘을 통한 피부색 분석을 이용하여, 채혈이나 전용 기기를 필요로 하지 않고 빌리루빈 농도를 추정합니다. 예를 들어, 2024년 7월, 일본의 기술 기업인 코니카미놀타는 노르웨이의 디지털 헬스케어 기업인 Picterus AS와 제휴를 맺고, 비침습적 황달 선별 검사 솔루션을 강화했습니다. 이번 제휴를 통해 스마트폰 기반 이미지 촬영 기술을 활용하여 선별 검사의 정확도를 유지하면서 조기 발견을 지원하고, 자원이 제한된 환경에서 의료 서비스 접근성을 높이며, 적시적인 개입을 가능하게 하고 있습니다. 또한, 이 솔루션은 병원의 진단 장비에 대한 의존도를 낮추고, 지역 사회 및 재택 간호 환경에서 현장 진단(POC) 선별 검사를 촉진합니다. 또한, 의료 종사자들에게 비용 대비 효과가 높고 사용하기 쉬운 기술을 제공함으로써, 확장성이 뛰어난 신생아 선별 검사 프로그램을 지원하고 있습니다.

자주 묻는 질문

  • 신생아 황달 치료 시장 규모는 어떻게 변화하고 있나요?
  • 신생아 황달 치료 시장의 성장 요인은 무엇인가요?
  • 신생아 황달 치료 시장에서 주목할 만한 기술 동향은 무엇인가요?
  • 출생률 상승이 신생아 황달 치료 시장에 미치는 영향은 무엇인가요?
  • 신생아 황달 치료 시장에서 주요 기업들은 어떤 기술에 주력하고 있나요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향 및 전략

제5장 최종 이용 산업 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁 및 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 TAM(Total Addressable Market) 규모

제9장 시장 세분화

제10장 지역별 및 국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황 및 투자환경

제36장 경쟁 구도 및 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 경쟁 벤치마킹 및 대시보드

제39장 시장에서 주목 받는 스타트업

제40장 주요 인수합병(M&A)

제41장 시장 잠재력이 높은 국가, 부문 및 전략

제42장 부록

AJY 26.07.15

Newborn jaundice treatment refers to medical interventions used to lower elevated bilirubin levels in infants that lead to yellowing of the skin and eyes. It includes therapeutic techniques that assist in breaking down or eliminating excess bilirubin from the infant's bloodstream to avoid complications. These treatments are intended to restore normal bilirubin levels safely while supporting healthy neonatal development.

The primary device types of newborn jaundice treatment include overhead phototherapy units, portable phototherapy units, and other device types. Overhead phototherapy units refer to fixed systems installed above the infant that provide controlled light exposure to reduce bilirubin levels in a clinical setting. The various modalities involved include conventional phototherapy, light emitting diode phototherapy, and fiber optic phototherapy, and the services include diagnostic and screening services, therapeutic and nursing services, and support and monitoring services. The various technologies involved include light emitting diode light sources, fluorescent, halogen, and fiberoptic systems, and they are utilized by several end users such as hospitals, neonatal intensive care units, pediatric clinics, and homecare settings.

Tariffs are influencing the newborn jaundice treatment market by raising the cost of imported phototherapy equipment, LED lighting systems, and specialized neonatal care devices used in hospitals and homecare environments. This is affecting affordability and procurement timelines, particularly in import-dependent regions such as Asia-Pacific and Latin America. Segments such as LED phototherapy systems and portable devices are most impacted because of their dependence on advanced optical and electronic components sourced globally. However, tariffs are also encouraging local production of neonatal care equipment, reinforcing regional supply chains, and driving innovation in affordable phototherapy solutions for newborn care.

The newborn jaundice treatment market research report is one of a series of new reports from The Business Research Company that provides newborn jaundice treatment market statistics, including newborn jaundice treatment industry global market size, regional shares, competitors with a newborn jaundice treatment market share, detailed newborn jaundice treatment market segments, market trends and opportunities, and any further data you may need to thrive in the newborn jaundice treatment industry. This newborn jaundice treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The newborn jaundice treatment market size has grown strongly in recent years. It will grow from $2.71 billion in 2025 to $2.84 billion in 2026 at a compound annual growth rate (CAGR) of 5.0%. The growth in the historic period can be attributed to high prevalence of neonatal jaundice cases globally, limited availability of advanced phototherapy devices in low-resource settings, reliance on conventional fluorescent lamp-based treatment systems, delayed diagnosis of hyperbilirubinemia in newborns, lack of standardized neonatal screening protocols.

The newborn jaundice treatment market size is expected to see strong growth in the next few years. It will grow to $3.49 billion by 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to rising adoption of LED-based phototherapy systems, increasing focus on early neonatal screening programs, growing demand for home-based newborn care solutions, advancements in non-invasive bilirubin monitoring technologies, expansion of neonatal intensive care infrastructure globally. Major trends in the forecast period include LED-based intensive phototherapy systems for rapid bilirubin reduction in neonates, fiber-optic blanket phototherapy enabling continuous treatment with minimal infant disruption, smart bilirubin monitoring systems integrated with real-time phototherapy adjustment, portable homecare phototherapy devices supporting early hospital discharge, dual-surface phototherapy units enhancing treatment efficiency in neonatal intensive care.

The rising birth rates are expected to drive the growth of the newborn jaundice treatment market in the coming years. Birth rates refer to the number of live births within a specific population during a given period, reflecting overall population growth and reproductive patterns. The increase in birth rates is supported by improved access to maternal healthcare, population expansion, and favorable government policies in certain regions, resulting in a larger number of newborns requiring postnatal care. Newborn jaundice treatment contributes to this trend by supporting early diagnosis and effective management of bilirubin levels in the expanding neonatal population through phototherapy and related treatment methods, thereby lowering the risk of complications. For instance, in July 2025, according to the Office for National Statistics, a UK-based government department, there were 594,677 live births recorded in England and Wales in 2024, an increase of 3,605 births (0.6%) compared to 2023, marking the first increase since 2021. Therefore, rising birth rates are driving the growth of the newborn jaundice treatment market.

Leading companies operating in the newborn jaundice treatment market are focusing on advanced non-invasive screening solutions, such as smartphone-based bilirubin detection technologies, to support early diagnosis and improve accessibility to care. Smartphone-based bilirubin detection uses mobile imaging and algorithm-based analysis of skin coloration to estimate bilirubin levels without requiring blood sampling or specialized equipment. For instance, in July 2024, Konica Minolta, a Japan-based technology company, collaborated with Picterus AS, a Norway-based digital health company, to strengthen non-invasive jaundice screening solutions. The collaboration utilizes smartphone-based imaging to support early detection, improve accessibility in low-resource settings, and enable timely intervention while maintaining screening accuracy. In addition, the solution reduces dependence on hospital-based diagnostic equipment and facilitates point-of-care screening in community and homecare environments. It also supports scalable neonatal screening programs by providing cost-effective and user-friendly technology for healthcare professionals.

In February 2026, Natus Sensory, a US-based medical technology company, acquired TheraB Medical for an undisclosed amount. Through this acquisition, Natus Sensory expanded its neonatal care portfolio by integrating wearable phototherapy technology, strengthening innovation in bilirubin management solutions, and broadening treatment accessibility across hospital and alternative care environments. TheraB Medical is an Israel-based medical device company specializing in wearable phototherapy solutions for neonatal jaundice management.

Major companies operating in the newborn jaundice treatment market are Koninklijke Philips N. V., GE HealthCare Technologies, Dragerwerk AG & Co. KGaA, Heal Force Bio-Meditech Holdings Limited, Atom Medical, Ningbo David Medical Device, Fanem Ltd., MTTS Inc., Phoenix Medical Systems, Olidef Medical, Dixion Vertrieb Medizinischer Gerate GmbH, Anandic Medical Systems AG, Weyer GmbH, AVI Healthcare Pvt. Ltd., Nice Neotech, Natus Medical, Ibis Medical, Novos Medical Systems, GINEVRI Srl, Solarc Systems Inc., Cobams Srl, Kay & Company, Nareena Lifesciences Private Limited, Alfamedic, Delta

North America was the largest region in the newborn jaundice treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the newborn jaundice treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the newborn jaundice treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The newborn jaundice treatment market consists of revenues earned by entities by providing services such as diagnostic testing services, phototherapy treatment services, neonatal monitoring services, bilirubin screening services, and neonatal nursing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The newborn jaundice treatment market also includes sales of phototherapy devices, bilirubin monitoring systems, fiber optic phototherapy blankets, and neonatal care equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Newborn Jaundice Treatment Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses newborn jaundice treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for newborn jaundice treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The newborn jaundice treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Device Type: Overhead Phototherapy Units; Portable Phototherapy Units; Other Device Types
  • 2) By Modality: Conventional Phototherapy; Light Emitting Diode Phototherapy; Fiber Optic Phototherapy
  • 3) By Service Type: Diagnostic And Screening Services; Therapeutic And Nursing Services; Support And Monitoring Services
  • 4) By Technology: Light Emitting Diode Light Sources; Fluorescent; Halogen; Fiberoptic
  • 5) By End User: Hospitals; Neonatal Intensive Care Units; Pediatric Clinics; Homecare Settings
  • Subsegments:
  • 1) By Overhead Phototherapy Units: Light Emitting Diode Overhead Phototherapy Units; Fluorescent Lamp Overhead Phototherapy Units; Halogen Lamp Overhead Phototherapy Units; Double Surface Overhead Phototherapy Units
  • 2) By Portable Phototherapy Units: Wearable Phototherapy Blanket Units; Fiber Optic Phototherapy Pad Units; Portable Light Emitting Diode Phototherapy Units; Compact Handheld Phototherapy Units
  • 3) By Other Device Types: Phototherapy Bassinet Systems; Phototherapy Incubator Integrated Systems; Combination Phototherapy And Warming Units; Multisurface Phototherapy Systems
  • Companies Mentioned: Koninklijke Philips N.V.; GE HealthCare Technologies; Dragerwerk AG & Co. KGaA; Heal Force Bio-Meditech Holdings Limited; Atom Medical; Ningbo David Medical Device; Fanem Ltd.; MTTS Inc.; Phoenix Medical Systems; Olidef Medical; Dixion Vertrieb Medizinischer Gerate GmbH; Anandic Medical Systems AG; Weyer GmbH; AVI Healthcare Pvt. Ltd.; Nice Neotech; Natus Medical; Ibis Medical; Novos Medical Systems; GINEVRI Srl; Solarc Systems Inc.; Cobams Srl; Kay & Company; Nareena Lifesciences Private Limited; Alfamedic; Delta
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Newborn Jaundice Treatment Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Newborn Jaundice Treatment Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Newborn Jaundice Treatment Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Newborn Jaundice Treatment Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 LED-Based Intensive Phototherapy Systems For Rapid Bilirubin Reduction In Neonates
    • 4.2.2 Fiber-Optic Blanket Phototherapy Enabling Continuous Treatment With Minimal Infant Disruption
    • 4.2.3 Smart Bilirubin Monitoring Systems Integrated With Real-Time Phototherapy Adjustment
    • 4.2.4 Portable Homecare Phototherapy Devices Supporting Early Hospital Discharge
    • 4.2.5 Dual-Surface Phototherapy Units Enhancing Treatment Efficiency In Neonatal Intensive Care

5. Newborn Jaundice Treatment Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Neonatal Intensive Care Units
  • 5.3 Pediatric Clinics
  • 5.4 Homecare Settings
  • 5.5 Other End Users

6. Newborn Jaundice Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Newborn Jaundice Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Newborn Jaundice Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Newborn Jaundice Treatment Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Newborn Jaundice Treatment Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Newborn Jaundice Treatment Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Newborn Jaundice Treatment Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Newborn Jaundice Treatment Market Segmentation

  • 9.1. Global Newborn Jaundice Treatment Market, Segmentation By Device Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Overhead Phototherapy Units, Portable Phototherapy Units, Other Device Types
  • 9.2. Global Newborn Jaundice Treatment Market, Segmentation By Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Conventional Phototherapy, Light Emitting Diode Phototherapy, Fiber Optic Phototherapy
  • 9.3. Global Newborn Jaundice Treatment Market, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic And Screening Services, Therapeutic And Nursing Services, Support And Monitoring Services
  • 9.4. Global Newborn Jaundice Treatment Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Light Emitting Diode Light Sources, Fluorescent, Halogen, Fiberoptic
  • 9.5. Global Newborn Jaundice Treatment Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Neonatal Intensive Care Units, Pediatric Clinics, Homecare Settings, Other End Users
  • 9.6. Global Newborn Jaundice Treatment Market, Sub-Segmentation Of Overhead Phototherapy Units, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Light Emitting Diode Overhead Phototherapy Units, Fluorescent Lamp Overhead Phototherapy Units, Halogen Lamp Overhead Phototherapy Units, Double Surface Overhead Phototherapy Units
  • 9.7. Global Newborn Jaundice Treatment Market, Sub-Segmentation Of Portable Phototherapy Units, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Wearable Phototherapy Blanket Units, Fiber Optic Phototherapy Pad Units, Portable Light Emitting Diode Phototherapy Units, Compact Handheld Phototherapy Units
  • 9.8. Global Newborn Jaundice Treatment Market, Sub-Segmentation Of Other Device Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Phototherapy Bassinet Systems, Phototherapy Incubator Integrated Systems, Combination Phototherapy And Warming Units, Multisurface Phototherapy Systems

10. Newborn Jaundice Treatment Market Regional And Country Analysis

  • 10.1. Global Newborn Jaundice Treatment Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Newborn Jaundice Treatment Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Newborn Jaundice Treatment Market

  • 11.1. Asia-Pacific Newborn Jaundice Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Newborn Jaundice Treatment Market

  • 12.1. China Newborn Jaundice Treatment Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Newborn Jaundice Treatment Market

  • 13.1. India Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Newborn Jaundice Treatment Market

  • 14.1. Japan Newborn Jaundice Treatment Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Newborn Jaundice Treatment Market

  • 15.1. Australia Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Newborn Jaundice Treatment Market

  • 16.1. Indonesia Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Newborn Jaundice Treatment Market

  • 17.1. South Korea Newborn Jaundice Treatment Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Newborn Jaundice Treatment Market

  • 18.1. Taiwan Newborn Jaundice Treatment Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Newborn Jaundice Treatment Market

  • 19.1. South East Asia Newborn Jaundice Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Newborn Jaundice Treatment Market

  • 20.1. Western Europe Newborn Jaundice Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Newborn Jaundice Treatment Market

  • 21.1. UK Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Newborn Jaundice Treatment Market

  • 22.1. Germany Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Newborn Jaundice Treatment Market

  • 23.1. France Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Newborn Jaundice Treatment Market

  • 24.1. Italy Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Newborn Jaundice Treatment Market

  • 25.1. Spain Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Newborn Jaundice Treatment Market

  • 26.1. Eastern Europe Newborn Jaundice Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Newborn Jaundice Treatment Market

  • 27.1. Russia Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Newborn Jaundice Treatment Market

  • 28.1. North America Newborn Jaundice Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Newborn Jaundice Treatment Market

  • 29.1. USA Newborn Jaundice Treatment Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Newborn Jaundice Treatment Market

  • 30.1. Canada Newborn Jaundice Treatment Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Newborn Jaundice Treatment Market

  • 31.1. South America Newborn Jaundice Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Newborn Jaundice Treatment Market

  • 32.1. Brazil Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Newborn Jaundice Treatment Market

  • 33.1. Middle East Newborn Jaundice Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Newborn Jaundice Treatment Market

  • 34.1. Africa Newborn Jaundice Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Newborn Jaundice Treatment Market, Segmentation By Device Type, Segmentation By Modality, Segmentation By Service Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Newborn Jaundice Treatment Market Regulatory and Investment Landscape

36. Newborn Jaundice Treatment Market Competitive Landscape And Company Profiles

  • 36.1. Newborn Jaundice Treatment Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Newborn Jaundice Treatment Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Newborn Jaundice Treatment Market Company Profiles
    • 36.3.1. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. GE HealthCare Technologies Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Dragerwerk AG & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Heal Force Bio-Meditech Holdings Limited Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Atom Medical Overview, Products and Services, Strategy and Financial Analysis

37. Newborn Jaundice Treatment Market Other Major And Innovative Companies

  • Ningbo David Medical Device, Fanem Ltd., MTTS Inc., Phoenix Medical Systems, Olidef Medical, Dixion Vertrieb Medizinischer Gerate GmbH, Anandic Medical Systems AG, Weyer GmbH, AVI Healthcare Pvt. Ltd., Nice Neotech, Natus Medical, Ibis Medical, Novos Medical Systems, GINEVRI Srl, Solarc Systems Inc.

38. Global Newborn Jaundice Treatment Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Newborn Jaundice Treatment Market

41. Newborn Jaundice Treatment Market High Potential Countries, Segments and Strategies

  • 41.1 Newborn Jaundice Treatment Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Newborn Jaundice Treatment Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Newborn Jaundice Treatment Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
문의하기